Business of Optometry

Top Story

STAAR Surgical receives approval of EVO Visian toric ICL from Health Canada

September 23, 2016

STAAR Surgical announced the Medical Devices Bureau of Health Canada approved the EVO Visian toric ICL for distribution in Canada.

In contrast to traditional contact lenses that are placed on the surface of the eye, the EVO toric ICL is placed inside the eye between the iris and natural lens, where it stays indefinitely, according to a company press release.

Heidelberg receives FDA clearance to market Spectralis OCT glaucoma module

September 23, 2016
Heidelberg Engineering received 510(k) clearance from the FDA to market the Spectralis OCT Glaucoma Module Premium Edition, which creates an anatomic map unique to each…

Nicox reports €12.3 million loss in first half of 2016

September 23, 2016
Nicox reported a net loss of 12.3 million in the first 6 months of 2016, excluding discontinued operations, compared with a net loss of 10.1 million reported during the…

GenSight Biologics expands trial of Leber's hereditary optic neuropathy treatment to include teenage patients

September 22, 2016
GenSight Biologics announced that regulatory agencies and ethics committees in the United States, France and the United Kingdom have approved a protocol amendment to…
COPE CME CE

Ocular Surface Diseases, Disorders, & Dysfunctions: Volume 2, Number 1

This activity is supported by an educational grant from Shire.

Maintenance of the health of the ocular surface is complex due to numer-ous potential challenges, including dry eye…
More »
Video
Meeting News Coverage

VIDEO: Sun Ophthalmics looks to improve customer care

May 8, 2016
More »
Featured
Vision Expo West

Vision Expo West

Video
Meeting News Coverage

VIDEO: OCTANe Ophthalmology Technology Summit brings together industry leaders, investors, innovators

June 22, 2016
More »

STAAR Surgical receives approval of EVO Visian toric ICL from Health Canada

September 23, 2016
STAAR Surgical announced the Medical Devices Bureau of Health Canada approved the EVO Visian toric ICL for distribution in Canada. In contrast to…

Heidelberg receives FDA clearance to market Spectralis OCT glaucoma module

September 23, 2016
Heidelberg Engineering received 510(k) clearance from the FDA to market the Spectralis OCT Glaucoma Module Premium Edition, which creates an anatomic…

Nicox reports €12.3 million loss in first half of 2016

September 23, 2016
Nicox reported a net loss of 12.3 million in the first 6 months of 2016, excluding discontinued operations, compared with a net loss of 10.1 million…

GenSight Biologics expands trial of Leber's hereditary optic neuropathy treatment to include teenage patients

September 22, 2016
GenSight Biologics announced that regulatory agencies and ethics committees in the United States, France and the United Kingdom have approved a…

EyeGate receives grant to continue development of ocular bandage film

September 21, 2016
Jade Therapeutics, a subsidiary of EyeGate Pharmaceuticals, received $448,185 in funding from the U.S. Army Medical Research and Materiel Command for…

Roclatan achieves primary efficacy endpoint in phase 3 Mercury 1 trial

September 20, 2016
Roclatan, a fixed-dose prostaglandin combination eye drop, reduced IOP more than each of its individual components at all time points measured, thus…

Blog

BLOG: The revolving door of ophthalmic surgical company acquisitions and sales

September 20, 2016
The announcement by Johnson & Johnson that it plans to acquire Abbott Medical Optics for just more than $4 billion is the latest in a series of…

J&J leadership eyes AMO partnership as resource for advancing optometry

September 20, 2016
Johnson & Johnson looks to its planned acquisition of Abbott Medical Optics as instrumental in improving patients’ eye health experience…

Meeting News Coverage

Asahi Vision introduces lensmeter, lens checker in US

September 17, 2016
LAS VEGAS – Nagoya, Japan-based Asahi Vision announced the introduction of two products to the U.S. eye care market, the aLC-100 Lens Checker…

Johnson and Johnson to acquire Abbott Medical Optics for $4.325 billion

September 16, 2016
Johnson and Johnson announced that it has reached an agreement to acquire Abbott Medical Optics, a wholly owned subsidiary of Abbott Laboratories…

More Headlines »
morganatic-roan
morganatic-roan